Information Library

Connect with investigators, regulators and physicians - High-quality studies

To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.

See all

  • Sort by:
  • Most Recent
  • Title

  • QUINTILES EXTENDS PHASE I CAPACITY AND CAPABILITIES

    March 8, 2010 – Quintiles announced the opening of its expanded research facility in London, UK, increasing its Phase I capacity and extending its ability to drive progress in translational medicine.

  • New FDA Guidance on Antidiabetic Therapies

    December 11, 2009
    Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program.

  • Diagnosing an Underperforming Drug

    August 19, 2009
    Learn how Eidetics uncovered barriers to market success for a customer’s new product launch and delivered insights to optimize marketing and sales strategies.

  • Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.

    June 24, 2009
    Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009 (International Society for Pharmacoeconomics and Outcomes Research) on “The Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.”

  • Early phase strategies

    June 15, 2009
    Web cast about Early Phase Strategies.

  • QT Population Modeling and Simulation Case Study

    June 15, 2009
    The importance of determining the most strategic Phase I/IIa study conducted by leading specialists shouldn’t be understated. Gain insight into QT and Population Modeling & Simulation.

  • The Importance of Latin America

    June 8, 2009
    Video showing why Latin America’s a great option for Clinical trials. With a total population over 500 million people and only two major languages, you will find a world of opportunity in the region.

  • India Today: Quintiles Central Laboratory

    June 8, 2009
    Video explaining why India’s a great option for clinical trials. Benefits include access to patients, potential cost savings, experienced investigators, and state of the art technology.

  • Late Phase and Safety Services

    April 10, 2009
    Recent and pending regulatory changes have created an atmosphere of watchful waiting throughout the industry. While it may seem premature to initiate post-marketing studies to collect more “intelligent” safety data, Quintiles Late Phase & Safety Services anticipates that the need for expanded studies will soon spread.

  • QUINTILES CENTRAL LAB IN ARGENTINA RECEIVES CAP ACCREDIATION

    March 11, 2009 - Quintiles Central Lab in Buenos Aires is latest facility to be accredited in the world’s largest CAP-accredited lab network.

Page 1 of 1 (10 results)

Tell Us What You Think

Rate your Quintiles.com experience

Subscribe to Email Based on Your Interests

Set preferences